The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tailored immunotherapy approach with nivolumab in advanced transitional cell carcinoma (TITAN-TCC).
 
Marc-Oliver Grimm
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer; Roche Pharma AG; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Barbara Grün
Consulting or Advisory Role - Dres. Schlegel + Schmidt
Travel, Accommodations, Expenses - Celgene
 
Guenter Niegisch
Honoraria - AstraZeneca; Medac; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck/Pfizer; Pfizer; Roche Pharma AG; Sanofi/Aventis
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche Pharma AG
 
Martin Pichler
Stock and Other Ownership Interests - Blueprint Medicines; Deciphera; Exelixis; Nektar
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; MSD
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen; MSD
 
Florian Roghmann
Honoraria - Janssen (Inst); Merck (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Roche (Inst)
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Merck (Inst)
 
Bernd Schmitz-Dräger
Honoraria - Bayer; Cepheid; Hexal; Janssen
Consulting or Advisory Role - Atheneum; Bayer; Cepheid; Hexal
Research Funding - Arquer Diagnostics; Cepheid; Concile; Nextage; Nucleix
 
Gustavo Bruno Baretton
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - BMS Brazil; MSD; Roche
 
Marc Schmitz
No Relationships to Disclose
 
Susan Foller
Honoraria - Bristol Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Procept-Biorobotics; Roche Pharma AG
Consulting or Advisory Role - Ipsen; Merck/Pfizer; MSD; Roche
 
Katharina Leucht
Research Funding - Bristol-Myers Squibb
 
Ulrike Schumacher
No Relationships to Disclose
 
Martin Schostak
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD
 
Johannes Meran
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Roche
 
Wolfgang C. Loidl
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen Oncology; Roche Pharma AG
 
Friedemann Zengerling
Honoraria - Bayer Health; Bristol-Myers Squibb; Ipsen; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Bristol-Myers Squibb; IPSEN; Merck Serono; Merck Sharp & Dohme; Roche; Sanofi/Aventis
Travel, Accommodations, Expenses - Bayer Health; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche